| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |